LCTX logo

LCTX EBITDA Margin

Latest reported161.93%
LCTX Quarterly EBITDA Margin (-100.00% → 161.93%)
High-resolution chart · PNG

LCTX ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock EBITDA Margin — Quarterly
Period endingEBITDA Margin
161.927%
-266.7246%
-63.5896%
-803.423%
-172.4774%
-264.9134%
-108.0544%
-75.6814%
-399.929%
-442.036%
-217.3851%
-560.3531%
-156.062%
-252.9757%
-323.1854%
-179.5197%
-144.9374%
-132.0412%
-2,897.7083%
-392.6885%
-1,080.4989%
-2,308.5324%
-3,340.9639%
-1,835.0877%
-5,917.1717%
-4,053.012%
-737.7404%
-3,530.4147%
-4,028%
-6,707.8212%
-5,538.5965%
-3,618.1818%
-1,366.8317%
-2,806.4%
-1,529.5255%
-1,875.162%
-2,501.5748%
-2,755.6728%
-1,375.5937%
-2,221.5385%
-2,590.1186%
-3,756.8259%
-3,618.7387%
-1,848.3333%
-2,086.1888%
-2,108.3246%
-3,242.7385%
-1,931.657%
-2,448.8484%
-1,937.5489%
-811.623%
-1,696.6111%
-1,402.714%
-1,454.55%
-1,210.603%
-518.753%
-522.0602%
-837.2726%
-305.3603%
-307.5076%
-573.4416%
-444.8894%
-226.2962%
-273.8349%
-318.4419%
-171.5103%
232.6751%
-654.5635%
-254.4345%
-304.3384%
-336.3758%
-214.0517%
-211.6528%
-93.609%
-71.7932%
-64.293%
-135.8497%
-206.7209%
-443.3688%
-71.7289%
-441.5678%
-190.1229%
-207.238%
-167.5505%
-170.7856%
-378.1346%
-309.2864%
-239.2074%
-223.9381%
396.8952%
-50.1987%
-129.23%
-307.7371%
-321.8936%
-252.7117%
10.9724%
-951.6937%
-741.5096%
-362.148%
-2,515.6525%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.